CYBN
NYSE MKT
$8.28
Cybin Inc (CYBN)
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $48.04 (+480.19%)
Market Cap
$408M
Beta (5Y)
0.93
Price Chart
Valuation
Market Cap$408M
P/S278.25
P/B2.94
Profitability
Gross Profit (TTM)-$311K
EBITDA-$99M
EPS-$3.77
Growth & Risk
Beta (5Y)0.93
Sharpe Ratio0.19